Trial · NCT07904624
Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART)
NCT07904624, Not applicable, Not yet recruiting, National University Hospital, Singapore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART). Trials, record NCT07904624. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904624
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART)
- NCT number
- NCT07904624
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 1,000 participants, estimated
- Lead sponsor
- National University Hospital, Singapore
- Conditions
- Brain Injuries
- Interventions
- ART
- First posted
- 2026-10-29
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Outpatient rehabilitation dose (time) (single ART) | A2 (week 6; +/- 1 week) | Home ART duration metrics (duration/day/month, pattern date/time stamp, repetitions etc) (participant training log and extracted device metrics from ART) vs centre based therapy duration (single and combo ART only) |
| Primary | Outpatient rehabilitation dose (time) (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | Home ART duration metrics (duration/day/month, pattern date/time stamp, repetitions etc) (participant training log and extracted device metrics from ART) vs centre based therapy duration (single and combo ART only) |
| Primary | Adherence to Home ART (single ART) | A2 (week 6; +/- 1 week) | Home training compliancy. Participant percentage (%) compliancy for prescription of the relevant ART given to participants by the therapist. |
| Primary | Adherence to Home ART (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | Home training compliancy. Participant percentage (%) compliancy for prescription of the relevant ART given to participants by the therapist. |
| Primary | Device specific metrics (Single ART) | A2 (week 6; +/- 1 week) | e.g. HMAN: number of repetitions |
| Primary | Device specific metrics (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | e.g. HMAN: number of repetitions |
| Primary | Dropout rates (Single ART) | A4 (week 24; +/- 1 week) or withdrawn date | Dropout rates of the groups |
| Primary | Dropout rates (Combined ART and control) | A5 (1 year; +/- 1 week) or withdrawn date | Dropout rates of the groups |
| Primary | System usability scale (SUS) (0-100) (single ART) | A2 (week 6; +/- 1 week) | To quantify the usability of the ART. Higher scores mean a better outcome. |
| Primary | System usability scale (SUS) (0-100) (Combined ART) | A2 (week 6; +/- 1 week), A3 (week 24; +/- 1 week) | To quantify the usability of the ART. Higher scores mean a better outcome. |
1 to 10 of 29Source ClinicalTrials.gov
See all 29 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07904624
GET https://conductscience.org/api/trials/v1/NCT07904624/registered?page=2